New Times,
New Thinking.

Advertorial feature by Pfizer
  1. Spotlight on Policy
28 February 2020updated 09 Sep 2021 3:48pm

Defeating the diagnostic odyssey

The Conservative life peer reflects on her experiences of Ehlers–Danlos syndrome and what the government can do to better support rare disease treatment.

By Nicola Blackwood

A big frustration during my time as Minister for Rare Diseases was that, despite so much genuine progress, too many rare disease patients today face challenges I recognise from my own experience growing up.

My diagnosis took 30 years. This may seem shocking but it is far from unusual. For the one in 17 people in the UK who will be affected by a rare disease at some point in their lives they can expect to wait an average of four years for a diagnosis.

Subscribe to The New Statesman today from only £8.99 per month
Topics in this article : ,